European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.18% to 1,338.75 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and electronics conglomerate Philips (PHG), which rose 2.2% and 1.6% respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which were up 1.4% and 1% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which lost 10% and 3.4% respectively. They were followed by medical device maker EDAP TMS (EDAP) and the pharmaceutical company Sanofi (SNY), which dropped 4.2% and 1.8% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Trinity Biotech (TRIB), which advanced 24.1% and 10.4% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and pharmaceutical company Mereo BioPharma Group (MREO), which increased 5% and 3.2% respectively.
The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company AstraZeneca (AZN), which fell 3.4% and 1.6% respectively. They were followed by telecommunications operator Vodafone Group (VOD), which was down 1.5%.
Price: 3.72, Change: +0.08, Percent Change: +2.23
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。